Summary & Overview
CPT 43204: Endoscopic Sclerotherapy for Upper GI Enlarged Vessels
CPT code 43204 represents endoscopic sclerotherapy performed by inserting a flexible endoscope through the mouth and injecting a sclerosing solution into enlarged blood vessels, commonly used to control bleeding or treat variceal lesions in the upper gastrointestinal tract. This procedure is an important therapeutic option in gastroenterology and has implications for acute care, procedural reimbursement, and facility resource planning across the national payer landscape. Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find an overview of the clinical context for endoscopic sclerotherapy, typical sites of service such as hospital outpatient departments and ambulatory surgical centers, and what national payers commonly consider when covering endoscopic therapeutic procedures. The publication summarizes benchmarking information, common billing considerations, and coding context relevant to facility and professional claims. It also outlines where to expect variation in coverage and utilization and highlights areas where policy updates or payer-specific rules can affect prior authorization and claim adjudication. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 43204 describes the endoscopic injection of a sclerosing solution into enlarged blood vessels via a flexible endoscope inserted through the mouth. This procedure is an endoscopic therapeutic intervention intended to treat bleeding or variceal lesions in the upper gastrointestinal tract.
-
Service type: Endoscopic sclerotherapy using a flexible endoscope
-
Typical site of service: Hospital outpatient department or ambulatory surgical center, performed via oral endoscopic access
Clinical & Coding Specifications
Clinical Context
A typical patient is a middle-aged adult presenting with symptoms of upper gastrointestinal bleeding or recurrent iron-deficiency anemia found to have esophageal or gastric varices or prominent bleeding submucosal vessels on endoscopy. The gastroenterologist performs an upper endoscopy using a flexible endoscope passed through the mouth to visualize the esophagus, stomach, and duodenum. Upon identification of bleeding or high-risk dilated vessels (varices, bleeding ectatic vessels), the provider injects a sclerosing solution into or adjacent to the offending vessel to promote thrombosis and fibrosis, thereby controlling hemorrhage. The procedure is commonly performed in an endoscopy suite, ambulatory surgical center, or hospital operating room under moderate sedation or monitored anesthesia care. Pre-procedure evaluation includes assessment of anticoagulation status, coagulation studies, airway assessment, and informed consent. Post-procedure workflow includes observation for hemostasis, monitoring for pain or signs of perforation or aspiration, instructions for diet advancement, and documentation of the endoscopic findings and sclerotherapy details (solution type, volume, injection sites). Typical payors involved include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, and Medicare.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Professional component | Use when reporting the physician's professional services separate from technical components provided by another entity. |